1 insider bought €87k of shares over the last 90 days, the latest by McQUADE KATHRYN B., filed 11 Sept 2026.
Every trade that managers of Altria Group, Inc. disclose to SEC (Form 4) is tracked on this page. The company sits in the Food & Agriculture sector and is based in Richmond, United States. It was founded in 1985. Between 18 October 2025 and 18 October 2026, 10 insiders published 22 filings.
On the market, 1 insider bought (1 purchase totalling €87k) while 3 insiders sold (3 sales totalling €2.1M). Sales outweigh purchases by €2.0M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The largest single trade was a sale of €1.6M by Whitaker Charles N., published on 9 March 2026. Those buying include 1 senior executive.
The most recent open-market purchase was published on 11 September 2026, 37 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning.
Compared with its exchange (5,814 companies, median 19 filings), a count of 22 filings is above the norm. Over the whole record (from 2016), the tally stands at 4 purchases and 4 sales. The 10-K for the year ended 31 December 2025 shows 23.28 bn USD of revenue and 6.95 bn USD of net income and a dividend of 4.16 USD per share.
Elsewhere in the same sector, our signals recently picked up insider purchases at Village Farms International, Inc. and Orkla ASA. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analysts rate Altria Group, Inc. Hold (neutral), based on 11 analysts. Average price target: US$70.00.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 190 declarations
Altria Group, Inc. is a U.S.-listed company traded on the NYSE under the ticker MO, headquartered in Richmond, Virginia, United States. The company traces its heritage back to Philip Morris & Co. and was renamed Altria Group in 2003, after which it underwent a series of portfolio shifts and divestitures that left it focused on the domestic nicotine market. While the modern business is narrower than its former conglomerate structure, Altria remains one of the most recognizable names in U.S. tobacco, with deep roots in manufacturing, distribution, and brand building. ([altria.com](https://www.altria.com/en/about-altria/our-heritage?utm_source=openai))
Altria’s current operations are centered on two reportable segments: smokeable products and oral tobacco products. In smokeables, the company’s flagship franchise is Marlboro through Philip Morris USA, supplemented by brands such as Black & Mild and other niche cigarette and cigar offerings. In oral tobacco, Altria holds leading positions with Copenhagen and Skoal, and also markets on!, its oral nicotine pouch brand. Beyond these legacy categories, Altria has been building a smoke-free portfolio through assets such as NJOY, its e-vapor platform, and Horizon Innovations, a joint venture with JT Group for the U.S. commercialization of heated tobacco stick products. The strategic message is clear: preserve cash from combustible products while trying to grow or at least establish relevance in reduced-risk nicotine formats. ([altria.com](https://www.altria.com/about-altria/at_a_glance/corporate-fact-sheet?utm_source=openai))
From a competitive standpoint, Altria retains a strong U.S. market position thanks to iconic brands, a powerful distribution footprint, established retail relationships, and significant regulatory experience. Those strengths help support margins and cash generation, which has historically underpinned the company’s dividend appeal. However, the industry backdrop remains challenging: cigarette volumes continue to trend down structurally, the regulatory burden is heavy, illicit products are a recurring issue, and the transition toward smoke-free alternatives is still uneven. In other words, Altria combines a highly cash-generative incumbent franchise with a long-term secular decline in its core category. ([altria.com](https://www.altria.com/?utm_source=openai))
Recent developments underscore both resilience and execution risk. In the first quarter of 2025, Altria reported results ahead of market expectations and reaffirmed full-year guidance, even as cigarette volumes fell sharply and the company recorded a large impairment tied to NJOY following a patent dispute. The company also noted that, effective March 31, 2025, NJOY ACE devices and pods were prohibited from being imported, marketed, sold, and distributed in the United States due to an International Trade Commission order. For investors in France, Belgium, and Switzerland, MO is best viewed as a mature U.S. defensive equity: attractive for income and brand strength, but exposed to secular volume pressure and still dependent on successful smoke-free execution. ([businesswire.com](https://www.businesswire.com/news/home/20250427178410/en/Altria-Reports-2025-First-Quarter-Results-Reaffirms-Full-Year-Guidance?utm_source=openai))
Purchases our model currently ranks for the recommendations list.
All recommendationsInsider filings
Over the last 90 days, 2 filings published between 11 September and 16 October 2026: 1 open-market purchase by insiders for €87k. 1 other filing (not open-market purchases or sales: grants, options, plans, sale notices, block transfers). Largest amounts: McQUADE KATHRYN B. (Director), purchases of €87k.
Summary written automatically from public filings, without human review. General information, identical for every reader: it is not investment advice or a recommendation to buy or sell. Investing involves a risk of capital loss. Generated on 18 October 2026 (UTC)
Headquarters: Richmond, United States · Founded: 1985 · Wikipedia article
Source: Wikidata (CC0).
| Fiscal year end | Revenue | Net income | Diluted EPS | Dividend per share | Filing |
|---|---|---|---|---|---|
| Dec 2025 | 23.28 bn USD | 6.95 bn USD | 4.12 USD | 4.16 USD | 10-K |
| Dec 2024 | 24.02 bn USD | 11.26 bn USD | 6.54 USD | 4.00 USD | 10-K |
| Dec 2023 | 24.48 bn USD | 8.13 bn USD | 4.57 USD | 3.84 USD | 10-K |
| Dec 2022 | 25.10 bn USD | 5.76 bn USD | 3.19 USD | 3.68 USD | 10-K |
| Dec 2021 | 26.01 bn USD | 2.48 bn USD | 1.34 USD | 3.52 USD | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.